Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Study of Lapatinib Among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study

NCT03894410 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT03894410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03894410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Study of Lapatinib Among Metastatic Breast Cancer Patients in Clinical Practice: a Multicenter, Retrospective Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
January 10, 2019
Completion date
May 20, 2020
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer